INIS
african americans
100%
kidneys
54%
transplants
45%
biopsy
18%
data
9%
surgery
9%
patients
9%
therapy
9%
risks
9%
comparative evaluations
9%
receptors
9%
grafts
9%
induction
9%
antibodies
9%
doses
9%
steroids
9%
american hispanics
9%
Medicine and Dentistry
Kidney Graft
45%
Hispanic
36%
Acute Graft Rejection
27%
Mycophenolate Mofetil
27%
Tacrolimus
27%
Graft Survival
18%
Daclizumab
18%
Biopsy
18%
Transplantation
9%
Receptor Antibody
9%
Combination Therapy
9%
Steroid
9%
Immunosuppressive Drug
9%
Kidney Allograft
9%
Day of Surgery
9%
Patient
9%
Incidence
9%
Immunology and Microbiology
Transplantation
54%
Acute Graft Rejection
27%
Tacrolimus
27%
Mycophenolic Acid
27%
Daclizumab
18%
Survival
18%
Receptor Antibody
9%
Immunosuppressive Drug
9%
Allotransplantation
9%
IL-2 Receptor
9%
Kidney
9%
Incidence
9%
Dose
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
27%
Mycophenolate Mofetil
27%
Acute Graft Rejection
27%
Daclizumab
18%
Steroids
9%
Immunosuppressive Agent
9%
Receptor Antibody
9%
Incidence
9%
Biochemistry, Genetics and Molecular Biology
Survival
18%
Daclizumab
18%
Steroids
9%
Incidence
9%
Dose
9%
IL-2 Receptor
9%